Related Experiment Video
Updated: Dec 29, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Challenges in the Discovery of Novel Therapeutic Agents in Cancer
Ganji Purnachandra Nagaraju1, Mohammad Amjad Kamal2,3,4
1Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, United States.
Abstract:
One of the major challenges currently facing cancer therapy is the development of drug resistance either intrinsically or as a result of treatment. Treatment evasion is mediated by an intricate web of signalling cascades and adaptations caused by selective therapeutic pressure, leading to metastatic spread and patient death. Hence, discovering and designing novel therapeutic compounds and regimens based on specific alterations in the cancer microenvironment and capable of overcoming resistance to traditional therapies is necessary to improve cancer survival outcomes. These new therapeutic modalities should exhibit improved solubility, penetration capacity and bioavailability in the tumor microenvironment as well as enhanced target specificity compared to old generation compounds. The success of this endeavour will contribute to the advent of precision medicine leading to personalized therapeutic approaches for patients.
Insights
Developing novel cancer therapies is crucial to overcome drug resistance and improve patient survival. New treatments must enhance solubility, bioavailability, and target specificity for better outcomes in precision medicine.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- Cancer drug resistance, intrinsic or acquired, poses a significant therapeutic challenge, leading to treatment failure, metastasis, and mortality.
- Complex signaling pathways and adaptive mechanisms drive treatment evasion under selective pressure.
- There is a critical need for novel therapeutic compounds and regimens to combat resistance and improve survival rates.
Discussion:
- New therapeutic agents must be designed to target specific alterations within the tumor microenvironment.
- Enhanced solubility, tumor penetration, and bioavailability are essential properties for next-generation cancer drugs.
- Improved target specificity is required to overcome resistance to traditional chemotherapies.
Key Insights:
- Addressing drug resistance is paramount for advancing cancer treatment efficacy.
- Novel therapeutic strategies must focus on overcoming the adaptive mechanisms of cancer cells.
- Developing drugs with superior pharmacokinetic and pharmacodynamic properties is key.
Outlook:
- The development of advanced therapeutic modalities will facilitate the realization of precision medicine.
- Personalized therapeutic approaches tailored to individual patient profiles will improve cancer survival outcomes.
- Continued research into overcoming drug resistance is vital for future cancer therapy innovations.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Related Concept Videos
Drug Discovery: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer